Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

Table 4 Reasons for withdrawal from randomised trial treatment among 1434 men followed for 3 years

Reason	n ^*	%
New disease	35	2.4
Incompatible medication	92	6.4
Adverse reaction	63	4.4
Other significant condition	43	3.0
Noncompliance	5	0.3
Moved away	13	0.9
Patient decision	193	13.5
Raised creatinine	24	1.7
Other	73	5.1
Total	541	37.7

ISSN: 1745-6215